FASLG and lung cancer: In vitro, an RLR agonist Poly(I:C)-HMW (High Molecular Weight)/LyoVecTM [Poly(I:C)-HMW] sensitised in vitro human lung cancer cells to Fas ligand (FasL)-induced apoptosis by radiotherapy (301).